Abstract

PurposeIn the absence of a virus nucleic acid real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test and experienced radiologists, clinical diagnosis is challenging for viral pneumonia with clinical symptoms and CT signs similar to that of coronavirus disease 2019 (COVID-19). We developed an end-to-end automatic differentiation method based on CT images to identify COVID-19 pneumonia patients in real time.MethodsFrom January 18 to February 23, 2020, we conducted a retrospective study and enrolled 201 patients from two hospitals in China who underwent chest CT and RT-PCR tests, of which 98 patients tested positive for COVID-19 (118 males and 83 females, with an average age of 42 years). Patient CT images from one hospital were divided among training, validation and test datasets with an 80%:10%:10% ratio. An end-to-end representation learning method using a large-scale bi-directional generative adversarial network (BigBiGAN) architecture was designed to extract semantic features from the CT images. The semantic feature matrix was input for linear classifier construction. Patients from the other hospital were used for external validation. Differentiation accuracy was evaluated using a receiver operating characteristic curve.ResultsBased on the 120-dimensional semantic features extracted by BigBiGAN from each image, the linear classifier results indicated that the area under the curve (AUC) in the training, validation and test datasets were 0.979, 0.968 and 0.972, respectively, with an average sensitivity of 92% and specificity of 91%. The AUC for external validation was 0.850, with a sensitivity of 80% and specificity of 75%. Publicly available architecture and computing resources were used throughout the study to ensure reproducibility.ConclusionThis study provides an efficient recognition method for coronavirus disease 2019 pneumonia, using an end-to-end design to implement targeted and effective isolation for the containment of this communicable disease.

Highlights

  • Coronavirus disease 2019 (COVID-19) pneumonia infections continue to increase in China and worldwide

  • The COVID-19 positive group consisted of 60 males and 38 females, with an average age of 43 years

  • The reverse transcriptasepolymerase chain reaction (RT-PCR) test is the standard for the clinical diagnosis of COVID-19 infections, several limitations apply to its application [5]

Read more

Summary

Introduction

Coronavirus disease 2019 (COVID-19) pneumonia infections continue to increase in China and worldwide. As of April 6, 2019, the number of COVID-19 pneumonia cases globally was 1,210,956, resulting in more than 67,500 deaths [1, 2]. The virus nucleic acid real-time reverse transcriptasepolymerase chain reaction (RT-PCR) test is the current standard diagnostic method for diagnosing COVID-19 pneumonia [5], it has limitations such as its low production, severe conditions for proper implementation and the number of false negatives [6]. Typical radiological imaging of COVID-19 pneumonia has clearly demonstrated the destruction of pulmonary parenchyma, including interstitial inflammation and extensive consolidation [9,10,11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call